haloperidol has been researched along with Anesthesia Related Hyperthermia in 16 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Malignant syndrome is a disease characterized by high fever, extrapyramidal syndrome and dysautonomia recognized during or at the time of stopping administration of antipsychotic medication and it is the most severe and lethal side effect of antipsychotic medication." | 5.30 | [A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine]. ( Fujimoto, K; Konishi, K; Kubota, M; Ogawa, H, 1997) |
| "We present the case of a 35-year-old man who developed symptoms of the neuroleptic malignant syndrome (NMS) after taking prescribed, moderately high, therapeutic doses of haloperidol." | 3.67 | Neuroleptic malignant syndrome. ( Lucid, EJ; Martin, ML; Walker, RW, 1985) |
| "Malignant syndrome is a disease characterized by high fever, extrapyramidal syndrome and dysautonomia recognized during or at the time of stopping administration of antipsychotic medication and it is the most severe and lethal side effect of antipsychotic medication." | 1.30 | [A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine]. ( Fujimoto, K; Konishi, K; Kubota, M; Ogawa, H, 1997) |
| "A related syndrome, Malignant Hyperthermia (MH), is sometimes associated with central core disease." | 1.29 | Hyperthermic reaction to haloperidol with rigidity, associated to central core disease. ( Calore, EE; Cavaliere, MJ; Perez, NM; Razzouk, D; Russo, DH; Wakamatsu, A, 1994) |
| "The anaesthetic complication malignant hyperpyrexia (MH) is due to an elevation of the myoplasmic Ca2+ concentration." | 1.27 | Calmodulin in porcine malignant hyperpyrexia. ( Collins, SP; Denborough, MA; White, MD, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (68.75) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rock, W | 1 |
| Elias, M | 1 |
| Lev, A | 1 |
| Saliba, WR | 1 |
| Caroff, SN | 1 |
| Goekoop, JG | 1 |
| Carbaat, PA | 1 |
| Yoshii, F | 1 |
| Ishihara, T | 1 |
| Shinohara, Y | 1 |
| Nomura, K | 1 |
| Takagi, A | 1 |
| de Rohan Chabot, P | 1 |
| Elkharrat, D | 1 |
| Conso, F | 1 |
| Bismuth, C | 1 |
| Goulon, M | 1 |
| Calore, EE | 1 |
| Cavaliere, MJ | 1 |
| Perez, NM | 1 |
| Russo, DH | 1 |
| Wakamatsu, A | 1 |
| Razzouk, D | 1 |
| Byrd, RP | 1 |
| Lukeman, RW | 1 |
| Mathai, M | 1 |
| Mathew, MK | 1 |
| Konishi, K | 1 |
| Fujimoto, K | 1 |
| Kubota, M | 1 |
| Ogawa, H | 1 |
| Kaskey, GB | 1 |
| Nasr, S | 1 |
| Hon, CA | 1 |
| Landers, DF | 1 |
| Platts, AA | 1 |
| Fletcher, JE | 1 |
| Rosenberg, H | 1 |
| Lizzo, FH | 1 |
| Collins, SP | 1 |
| White, MD | 1 |
| Denborough, MA | 1 |
| Rampertaap, MP | 1 |
| Liskow, BI | 1 |
| Martin, ML | 1 |
| Lucid, EJ | 1 |
| Walker, RW | 1 |
| Castilla Cortázar, A | 1 |
| Alonso Alonso, JJ | 1 |
| Aguirre Errasti, C | 1 |
1 review available for haloperidol and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differ | 1986 |
15 other studies available for haloperidol and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
Topics: Adult; Antipsychotic Agents; Fatal Outcome; Haloperidol; Humans; Hyperglycemia; Male; Malignant Hype | 2009 |
The neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Autonomic Nervous System; Cognition Disorders; Consciousness Disorders; Diagno | 1980 |
Treatment of neuroleptic malignant syndrome with dantrolene.
Topics: Adult; Bipolar Disorder; Dantrolene; Haloperidol; Humans; Male; Malignant Hyperthermia; Muscle Rigid | 1982 |
[A case of malignant syndrome with persistent nystagmus and diplopia].
Topics: Adult; Diplopia; Female; Haloperidol; Humans; Lithium; Lithium Carbonate; Malignant Hyperthermia; Me | 1982 |
[Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
Topics: Adolescent; Basal Ganglia Diseases; Calcium; Dantrolene; Fever; Haloperidol; Humans; Male; Malignant | 1982 |
Hyperthermic reaction to haloperidol with rigidity, associated to central core disease.
Topics: Adult; Diagnosis, Differential; Female; Haloperidol; Humans; Malignant Hyperthermia; Muscles; Myopat | 1994 |
Catheter-associated central venous thrombosis.
Topics: Adult; Bipolar Disorder; Catheterization, Central Venous; Dantrolene; Female; Fluid Therapy; Haloper | 1996 |
[A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine].
Topics: Adult; Antipsychotic Agents; Anxiety; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Chl | 1997 |
A side effect of rapid neuroleptization.
Topics: Adult; Female; Haloperidol; Humans; Injections, Intramuscular; Malignant Hyperthermia | 1979 |
Effects of neuroleptic agents on rat skeletal muscle contracture in vitro.
Topics: Animals; Antipsychotic Agents; Diaphragm; Droperidol; Drug Synergism; Haloperidol; Halothane; In Vit | 1991 |
Effects of droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures: implications for malignant hyperthermia.
Topics: Animals; Caffeine; Contracture; Droperidol; Haloperidol; Halothane; Humans; Ketamine; Male; Malignan | 1989 |
Calmodulin in porcine malignant hyperpyrexia.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Brain Chemistry; Calmodulin; Cyclic AMP; Electrophores | 1987 |
Relationship between neuroleptic malignant syndrome and malignant hyperthermia.
Topics: Atracurium; Basal Ganglia Diseases; Depressive Disorder; Electroconvulsive Therapy; Haloperidol; Hum | 1985 |
Neuroleptic malignant syndrome.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Diagnosis, Differential; Haloperidol; Heat | 1985 |
[Malignant syndrome caused by neuroleptics. Rapid response to biperiden in a case of brief development].
Topics: Biperiden; Haloperidol; Humans; Male; Malignant Hyperthermia; Middle Aged; Piperidines | 1985 |